242 related articles for article (PubMed ID: 25921762)
1. The novel compound Z060228 inhibits assembly of the HBV capsid.
Guan H; Zhao G; Chen W; Wu G; Liu H; Jiang X; Li S; Wang LL
Life Sci; 2015 Jul; 133():1-7. PubMed ID: 25921762
[TBL] [Abstract][Full Text] [Related]
2. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations.
Wang XY; Wei ZM; Wu GY; Wang JH; Zhang YJ; Li J; Zhang HH; Xie XW; Wang X; Wang ZH; Wei L; Wang Y; Chen HS
Antivir Ther; 2012; 17(5):793-803. PubMed ID: 22668794
[TBL] [Abstract][Full Text] [Related]
5. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
[TBL] [Abstract][Full Text] [Related]
6. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379.
Berke JM; Dehertogh P; Vergauwen K; Mostmans W; Vandyck K; Raboisson P; Pauwels F
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094138
[TBL] [Abstract][Full Text] [Related]
8. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
[TBL] [Abstract][Full Text] [Related]
9. Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly.
Kang JA; Kim S; Park M; Park HJ; Kim JH; Park S; Hwang JR; Kim YC; Jun Kim Y; Cho Y; Sun Jin M; Park SG
Nat Commun; 2019 May; 10(1):2184. PubMed ID: 31097716
[TBL] [Abstract][Full Text] [Related]
10. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus.
Berke JM; Dehertogh P; Vergauwen K; Van Damme E; Mostmans W; Vandyck K; Pauwels F
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584155
[TBL] [Abstract][Full Text] [Related]
11. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M
Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
13. A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection.
Ko C; Bester R; Zhou X; Xu Z; Blossey C; Sacherl J; Vondran FWR; Gao L; Protzer U
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658963
[TBL] [Abstract][Full Text] [Related]
14. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.
Huber AD; Pineda DL; Liu D; Boschert KN; Gres AT; Wolf JJ; Coonrod EM; Tang J; Laughlin TG; Yang Q; Puray-Chavez MN; Ji J; Singh K; Kirby KA; Wang Z; Sarafianos SG
ACS Infect Dis; 2019 May; 5(5):750-758. PubMed ID: 30582687
[TBL] [Abstract][Full Text] [Related]
15. Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation.
Yang L; Wang YJ; Chen HJ; Shi LP; Tong XK; Zhang YM; Wang GF; Wang WL; Feng CL; He PL; Xu YB; Lu MJ; Tang W; Nan FJ; Zuo JP
Antiviral Res; 2016 Jan; 125():25-33. PubMed ID: 26611395
[TBL] [Abstract][Full Text] [Related]
16. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro.
Corcuera A; Stolle K; Hillmer S; Seitz S; Lee JY; Bartenschlager R; Birkmann A; Urban A
Antiviral Res; 2018 Oct; 158():135-142. PubMed ID: 30031759
[TBL] [Abstract][Full Text] [Related]
17. Interaction between nucleophosmin and HBV core protein increases HBV capsid assembly.
Jeong H; Cho MH; Park SG; Jung G
FEBS Lett; 2014 Mar; 588(6):851-8. PubMed ID: 24462683
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors.
Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H
Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828
[TBL] [Abstract][Full Text] [Related]
19. A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly.
Xi J; Gu Z; Sun C; Chen Z; Zhang T; Chen R; Liu T; Liao H; Zou J; Yang D; Xu Q; Wang J; Wei G; Cheng Z; Lu F; Chen X
Antiviral Res; 2023 Oct; 218():105715. PubMed ID: 37683938
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Discovery of
Yang Y; Yan Y; Yin J; Hu J; Cai X; Hu J; Xia J; Wang K; Tang N; Huang L
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
